A carregar...
Lenalidomide, an antiproliferative CLL drug
In this issue of Blood, Fecteau et al show that lenalidomide inhibits proliferation of chronic lymphocytic leukemia (CLL) cells in vitro by targeting cereblon. Thus far, the clinical activity of this drug in CLL was believed to be mainly via the microenvironment.(1)
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4155263/ https://ncbi.nlm.nih.gov/pubmed/25190749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-07-587360 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|